• LAST PRICE
    6.7800
  • TODAY'S CHANGE (%)
    Trending Down-0.0700 (-1.0219%)
  • Bid / Lots
    6.7200/ 5
  • Ask / Lots
    6.9800/ 3
  • Open / Previous Close
    6.8200 / 6.8500
  • Day Range
    Low 6.6700
    High 6.8600
  • 52 Week Range
    Low 6.3000
    High 11.9200
  • Volume
    101,374
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.85
TimeVolumeFENC
09:32 ET29416.81
09:36 ET9006.79
09:38 ET6006.8
09:45 ET3006.85
09:52 ET7176.85
09:54 ET6006.845
09:56 ET20436.85
10:08 ET2106.86
10:14 ET1416.84
10:21 ET77076.81
10:28 ET1006.805
10:32 ET12006.81
10:33 ET2496.811
10:35 ET1006.82
10:37 ET1006.81
10:39 ET35106.81
10:48 ET10006.8001
10:53 ET1006.82
10:55 ET21506.76
10:57 ET1206.77
11:02 ET7796.7999
11:08 ET20296.74
11:11 ET8006.7
11:13 ET1006.74
11:40 ET2006.725
11:45 ET18656.7
11:47 ET1556.6985
11:49 ET1006.695
11:51 ET2006.691
11:58 ET2246.6998
12:00 ET1006.7
12:02 ET2996.69
12:14 ET9426.715
12:16 ET2616.715
12:23 ET12836.67
12:27 ET1006.67
12:36 ET1006.69
12:54 ET11006.71
12:56 ET10006.69
12:57 ET3006.7
01:01 ET19936.69
01:03 ET5756.67
01:06 ET2006.69
01:08 ET1006.69
01:15 ET2006.7
01:19 ET1006.7
01:24 ET24936.745
01:30 ET7656.74
01:53 ET11006.795
01:55 ET4006.79
02:04 ET6006.79
02:08 ET2926.82
02:11 ET6006.825
02:13 ET4636.82
02:15 ET1006.83
02:18 ET2006.82
02:24 ET2006.81
02:29 ET1006.825
02:40 ET2976.82
02:51 ET1006.84
02:54 ET18606.78
02:56 ET3006.78
03:00 ET4006.76
03:02 ET4126.76
03:07 ET1006.77
03:21 ET1006.79
03:23 ET1006.79
03:25 ET2626.78
03:27 ET2006.76
03:30 ET1006.77
03:34 ET1006.78
03:39 ET1666.78
03:43 ET27106.76
03:45 ET12006.76
03:48 ET1006.77
03:50 ET11006.78
03:52 ET22276.77
03:54 ET1006.785
03:56 ET5696.78
03:57 ET7896.765
03:59 ET3006.78
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFENC
Fennec Pharmaceuticals Inc
187.2M
185.4x
---
United StatesCLLS
Cellectis SA
189.9M
-1.4x
---
United StatesTLSI
TriSalus Life Sciences Inc
202.1M
-3.4x
---
United StatesCAPR
Capricor Therapeutics Inc
176.6M
-6.5x
---
United StatesHOWL
Werewolf Therapeutics Inc
232.9M
-4.7x
---
United StatesMDWD
Mediwound Ltd
148.9M
-11.8x
---
As of 2024-05-31

Company Information

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

Contact Information

Headquarters
68 Tw Alexander Dr PO Box 13628RESEARCH TRIANGLE PARK, NC, United States 27709
Phone
919-636-4530
Fax
919-890-0490

Executives

Independent Chairman of the Board
Khalid Islam
Chief Executive Officer, Director
Rostislav Raykov
Chief Financial Officer
Robert Andrade
Chief Operating Officer
Adrian Haigh
Independent Director
Marco Brughera

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$187.2M
Revenue (TTM)
$45.0M
Shares Outstanding
27.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.34
EPS
$0.04
Book Value
$-0.43
P/E Ratio
185.4x
Price/Sales (TTM)
4.2
Price/Cash Flow (TTM)
65.8x
Operating Margin
13.89%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.